Literature DB >> 12034357

IL-7 withdrawal induces a stress pathway activating p38 and Jun N-terminal kinases.

Eva Rajnavolgyi1, Naima Benbernou, Bence Rethi, Della Reynolds, Howard A Young, Maria Magocsi, Kathrin Muegge, Scott K Durum.   

Abstract

IL-7 delivers survival signals to cells at an early stage in lymphoid development. In the absence of IL-7, pro-T cells undergo programmed cell death, which has previously been associated with a decline in Bcl-2 and translocation of Bax from cytosol to mitochondria. A new, earlier feature of IL-7 withdrawal was identified using an IL-7-dependent thymocyte line. We observed that withdrawal of IL-7 induced increased expression of jun and fos family member genes including c-jun, junB, junD, c-fos and fra2. This transient response peaked 3-4 h after IL-7 was withdrawn and resulted in increased DNA-binding activity of AP-1 and in a change in the composition of the Jun/Fos family dimers shown by electrophoretic mobility shift and supershift assays. Induction of jun and fos genes and the increased DNA-binding activity of AP-1 were attributable to the phosphorylation-induced activation of the stress kinases p38 and JNK and were blocked by the chemical kinase inhibitors SB203580 and SB202190. The stress response contributed to cell death following IL-7 withdrawal as shown by blocking the activity of the stress (MAP) kinases or by blocking the production of c-Jun and c-Fos using antisense oligonucleotides.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034357     DOI: 10.1016/s0898-6568(02)00026-8

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  9 in total

1.  The major isoforms of Bim contribute to distinct biological activities that govern the processes of autophagy and apoptosis in interleukin-7 dependent lymphocytes.

Authors:  Shannon M Ruppert; Wenqing Li; Ge Zhang; Adina L Carlson; Arati Limaye; Scott K Durum; Annette R Khaled
Journal:  Biochim Biophys Acta       Date:  2012-06-21

2.  Interleukin-7 is required for CD4(+) T cell activation and autoimmune neuroinflammation.

Authors:  Brian R Lawson; Rosana Gonzalez-Quintial; Theodoros Eleftheriadis; Michael A Farrar; Stephen D Miller; Karsten Sauer; Dorian B McGavern; Dwight H Kono; Roberto Baccala; Argyrios N Theofilopoulos
Journal:  Clin Immunol       Date:  2015-08-25       Impact factor: 3.969

3.  Increased CD4+ T cell levels during IL-7 administration of antiretroviral therapy-treated simian immunodeficiency virus-positive macaques are not dependent on strong proliferative responses.

Authors:  Amanda Leone; Mukta Rohankhedkar; Afam Okoye; Alfred Legasse; Michael K Axthelm; Francois Villinger; Michael Piatak; Jeffrey D Lifson; Brigitte Assouline; Michel Morre; Louis J Picker; Donald L Sodora
Journal:  J Immunol       Date:  2010-07-09       Impact factor: 5.422

Review 4.  Interlinking interleukin-7.

Authors:  Christina Kittipatarin; Annette R Khaled
Journal:  Cytokine       Date:  2007-09-04       Impact factor: 3.861

5.  Interleukin-7 regulates Bim proapoptotic activity in peripheral T-cell survival.

Authors:  Wen Qing Li; Tad Guszczynski; Julie A Hixon; Scott K Durum
Journal:  Mol Cell Biol       Date:  2009-11-23       Impact factor: 4.272

6.  Critical role for Rsk2 in T-lymphocyte activation.

Authors:  Jian-Xin Lin; Rosanne Spolski; Warren J Leonard
Journal:  Blood       Date:  2007-10-15       Impact factor: 22.113

7.  Cytokine-driven cell cycling is mediated through Cdc25A.

Authors:  Annette R Khaled; Dmitry V Bulavin; Christina Kittipatarin; Wen Qing Li; Michelle Alvarez; Kyungjae Kim; Howard A Young; Albert J Fornace; Scott K Durum
Journal:  J Cell Biol       Date:  2005-05-31       Impact factor: 10.539

Review 8.  The Role of IL-7 and IL-7R in Cancer Pathophysiology and Immunotherapy.

Authors:  Chunli Wang; Lingzu Kong; Seokmin Kim; Sunyoung Lee; Sechan Oh; Seona Jo; Inhwan Jang; Tae-Don Kim
Journal:  Int J Mol Sci       Date:  2022-09-08       Impact factor: 6.208

Review 9.  The Broad Immunomodulatory Effects of IL-7 and Its Application In Vaccines.

Authors:  Juan Huang; Zhiyao Long; Renyong Jia; Mingshu Wang; Dekang Zhu; Mafeng Liu; Shun Chen; Xinxin Zhao; Qiao Yang; Ying Wu; Shaqiu Zhang; Bin Tian; Sai Mao; Xumin Ou; Di Sun; Qun Gao; Anchun Cheng
Journal:  Front Immunol       Date:  2021-12-10       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.